Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib

Recent case reports provided alarming signals that treatment with bortezomib might be associated with cardiac events. In all reported cases, patients experiencing cardiac problems were previously or concomitantly treated with other chemotherapeutics including cardiotoxic anthracyclines. Therefore, i...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nowis, Dominika, Mączewski, Michał, Mackiewicz, Urszula, Kujawa, Marek, Ratajska, Anna, Wieckowski, Mariusz R., Wilczyński, Grzegorz M., Malinowska, Monika, Bil, Jacek, Salwa, Paweł, Bugajski, Marek, Wójcik, Cezary, Siński, Maciej, Abramczyk, Piotr, Winiarska, Magdalena, Dąbrowska-Iwanicka, Anna, Duszyński, Jerzy, Jakóbisiak, Marek, Golab, Jakub
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Investigative Pathology 2010
Témata:
Regular Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2877829/
https://ncbi.nlm.nih.gov/pubmed/20519734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2010.090690
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky